Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc. announced the presentation of new preclinical data for KT-579, a first-in-class, oral IRF5 degrader, …
Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial Zenas BioPharma, Inc. announced positive results from the Phase 2 …
Study Claims Ozempic Lowers Biological Age Researchers reveal that GLP-1 medication Ozempic may reduce biological age, offering new hope i…
Navigating Complex Injury Cases Efficiently Dealing with a serious injury case can be stressful and confusing, but there are steps you can…
Utah's Olympic Organizers in NYC Leaders of Utah's 2034 Winter Games are in New York City to show support for American athletes competing …
Isuzu FA Trophy Second Round Proper Draw Confirmed The draw for the Isuzu FA Trophy Second Round Proper has been announced, featuring 40 m…
CTD-ILD Burden on Older Patients and Women The incidence and prevalence of Connective Tissue Diseases with Interstitial Lung Disease (CTD-…
Banks' Stampede for Deposits to Intensify The competition for deposits among local commercial banks is expected to escalate, as the centra…
OPPO and Ballet Philippines Partnership OPPO has announced a partnership with Ballet Philippines to promote Filipino artistry, coinciding …
Government Reveals Environmental Regulation Reforms The government has announced changes to environmental regulations in an effort to boos…
Community Pharmacies and BioPharma: Advancing Whole-Patient Care Together The healthcare landscape has become increasingly complex, with a…